AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 61 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $251,672 | -47.8% | 558,650 | -39.0% | 0.00% | – |
| Q3 2022 | $482,000 | -19.7% | 915,695 | -22.9% | 0.00% | – |
| Q2 2022 | $600,000 | -76.8% | 1,187,293 | +5.6% | 0.00% | -100.0% |
| Q1 2022 | $2,587,000 | -52.0% | 1,124,789 | -0.8% | 0.00% | 0.0% |
| Q4 2021 | $5,388,000 | -40.3% | 1,134,351 | -0.1% | 0.00% | -50.0% |
| Q3 2021 | $9,031,000 | +14.7% | 1,136,050 | +0.4% | 0.00% | 0.0% |
| Q2 2021 | $7,873,000 | -12.5% | 1,131,059 | -0.5% | 0.00% | 0.0% |
| Q1 2021 | $9,002,000 | +163.1% | 1,136,673 | +161.5% | 0.00% | +100.0% |
| Q4 2020 | $3,421,000 | +7.8% | 434,725 | -2.9% | 0.00% | 0.0% |
| Q3 2020 | $3,174,000 | -24.5% | 447,727 | -1.5% | 0.00% | 0.0% |
| Q2 2020 | $4,206,000 | +114.0% | 454,734 | +7.9% | 0.00% | 0.0% |
| Q1 2020 | $1,965,000 | -41.8% | 421,565 | -4.6% | 0.00% | 0.0% |
| Q4 2019 | $3,377,000 | +1.0% | 442,050 | +1.6% | 0.00% | 0.0% |
| Q3 2019 | $3,345,000 | +23.3% | 434,999 | +9.8% | 0.00% | 0.0% |
| Q2 2019 | $2,713,000 | -16.5% | 396,082 | -1.8% | 0.00% | 0.0% |
| Q1 2019 | $3,248,000 | +2360.6% | 403,424 | +2182.7% | 0.00% | – |
| Q4 2018 | $132,000 | -27.9% | 17,673 | -7.7% | 0.00% | – |
| Q3 2018 | $183,000 | +1.1% | 19,155 | +11.7% | 0.00% | – |
| Q2 2018 | $181,000 | +53.4% | 17,143 | +44.1% | 0.00% | – |
| Q1 2018 | $118,000 | +162.2% | 11,900 | +14.6% | 0.00% | – |
| Q4 2016 | $45,000 | -78.8% | 10,386 | -68.6% | 0.00% | – |
| Q3 2016 | $212,000 | -22.3% | 33,026 | -41.3% | 0.00% | – |
| Q2 2016 | $273,000 | – | 56,234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
| Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
| Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
| Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
| Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
| Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
| Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
| Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
| Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
| Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |